{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T23:33:01.530259+00:00","company":{"ticker":"USAQ","cik":856984,"company_name":"QHSLab, Inc."},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"4a94f2f2a3a965adec0d8da15d0a3e7baf223803","cik":856984,"ticker":"USAQ","company_name":"QHSLab, Inc.","filed_at":"2026-01-23T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Repurchase Agreement","agreement_type":"other","counterparty":"MedScience Research Group, Inc.","effective_date":null,"item_codes_triggered":["1.01"],"value_text":null},"claim":"QHSLab, Inc. terminated Repurchase Agreement with MedScience Research Group, Inc..","evidence_excerpt":"QHSLab, Inc. (the “Company”) consummated a Note Repurchase Agreement (the “Repurchase Agreement”) with MedScience Research Group, Inc., a Florida corporation (“MedScience”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-003438","anchor_url":"https://secwatch.observer/filing/0001493152-26-003438#claim-4a94f2f2a3a965adec0d8da15d0a3e7baf223803","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856984/000149315226003438/0001493152-26-003438-index.htm"},{"fact_type":"material_agreement","fact_key":"7dee264ff7bfb8ddb27939a0b029a83463c1b3af","cik":856984,"ticker":"USAQ","company_name":"QHSLab, Inc.","filed_at":"2026-01-02T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Promissory Note Modification and Partial Conversion Agreement","agreement_type":"other","counterparty":"Alex Mirakian MD PA","effective_date":"2025-12-31","item_codes_triggered":["1.01"],"value_text":null},"claim":"QHSLab, Inc. amended Promissory Note Modification and Partial Conversion Agreement with Alex Mirakian MD PA (effective 2025-12-31).","evidence_excerpt":"On December 31, 2025, QHSLab, Inc., (the Company), entered into a Promissory Note Modification and Partial Conversion Agreement (the Modification Agreement) with Alex Mirakian MD PA (the Holder), in connection with a previously issued convertible promissory note dated May 7, 2021 (the Original Note).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-000092","anchor_url":"https://secwatch.observer/filing/0001493152-26-000092#claim-7dee264ff7bfb8ddb27939a0b029a83463c1b3af","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856984/000149315226000092/0001493152-26-000092-index.htm"},{"fact_type":"material_agreement","fact_key":"796ca872f1114c0064eb23b0c816b13b0ea86a08","cik":856984,"ticker":"USAQ","company_name":"QHSLab, Inc.","filed_at":"2025-12-29T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Subscription Agreements","agreement_type":"equity_purchase","counterparty":"two accredited investors","effective_date":"2025-12-26","item_codes_triggered":["1.01"],"value_text":"approximately $500,000"},"claim":"QHSLab, Inc. entered into Subscription Agreements with two accredited investors valued at approximately $500,000 (effective 2025-12-26).","evidence_excerpt":"On December 26, 2025, QHSLab, Inc. (the “Company”) accepted subscription agreements from two accredited investors for the purchase of approximately $500,000 of the Company’s common stock and warrants","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-029222","anchor_url":"https://secwatch.observer/filing/0001493152-25-029222#claim-796ca872f1114c0064eb23b0c816b13b0ea86a08","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856984/000149315225029222/0001493152-25-029222-index.htm"},{"fact_type":"debt_financing","fact_key":"cb7b32e9d2ac10d874d29f0e77a9a16ac79bc3f9","cik":856984,"ticker":"USAQ","company_name":"QHSLab, Inc.","filed_at":"2025-11-18T23:59:59+00:00","payload":{"counterparty":null,"effective_date":"2025-11-18","event":"default","instrument_type":"convertible_notes","interest_rate_text":"18 percent per annum","item_codes_triggered":["2.04"],"maturity_text":null,"principal_text":"in excess of $1.4 million"},"claim":"QHSLab, Inc. reported a default on convertible notes of in excess of $1.4 million at 18 percent per annum.","evidence_excerpt":"The Notes, which had been in default and bore interest at a default rate of 18 percent per annum, had an aggregate outstanding balance consisting of principal and accrued interest in excess of $1.4 million as of the date of redemption.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-023990","anchor_url":"https://secwatch.observer/filing/0001493152-25-023990#claim-cb7b32e9d2ac10d874d29f0e77a9a16ac79bc3f9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/856984/000149315225023990/0001493152-25-023990-index.htm"}]}